July 30, 2021 - ROSEN LOGO.jpg
ROSEN, NATIONAL TRIAL LAWYERS, Encourages SCYNEXIS, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – SCYX
18 nov. 2023 15h33 HE | The Rosen Law Firm PA
NEW YORK, Nov. 18, 2023 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of securities of...
QualTex launches cel
QualTex launches cellular therapy testing services
13 oct. 2020 08h00 HE | BioBridge Global
San Antonio, Texas, Oct. 13, 2020 (GLOBE NEWSWIRE) -- QualTex Laboratories, a subsidiary of San Antonio-based nonprofit BioBridge Global, has expanded its offerings to...
Logo.png
Guardion Health Sciences Adds Experienced Vice President and Chief Financial Officer to Executive Management Team
21 juil. 2020 08h30 HE | Guardion Health Sciences, Inc.
Newly-Appointed CFO Andrew Schmidt BringsExtensive and Wide-Ranging Public Company Experience San Diego, California, July 21, 2020 (GLOBE NEWSWIRE) -- Guardion Health Sciences, Inc. (“Guardion”...
FINAL_LOGO-02.jpg
Axim® Biotechnologies Earns GMP License From Dutch Ministry of Health to Produce Cannabinoid-Based Pharmaceutical Products
16 oct. 2018 09h00 HE | AXIM BIOTECHNOLOGIES, INC
New License Allows Leading Cannabinoid Biopharmaceutical Company to Advance Production of Clinical Trial Products NEW YORK, Oct. 16, 2018 (GLOBE NEWSWIRE) -- AXIM® Biotechnologies, Inc. (“AXIM®...
AXIM Biotech Announces First-Ever Successful Achievement of Proprietary cGMP Extraction and Manufacturing Methods for Pure Cannabinoid Molecules
27 févr. 2018 09h00 HE | AXIM BIOTECHNOLOGIES, INC
NEW YORK, Feb. 27, 2018 (GLOBE NEWSWIRE) -- AXIM® Biotechnologies (OTC:AXIM) (“AXIM”), the world leader in cannabinoid research and development, today announced the first-ever successful execution...